ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,121,701 | -57.5% | 1,300,221 | -33.4% | 0.01% | -54.2% |
| Q2 2023 | $9,705,317 | +4.7% | 1,952,780 | +4.1% | 0.02% | -7.7% |
| Q1 2023 | $9,271,140 | -8.5% | 1,876,749 | +16.5% | 0.03% | -18.8% |
| Q4 2022 | $10,134,775 | +12.7% | 1,611,252 | +93.4% | 0.03% | +3.2% |
| Q3 2022 | $8,996,000 | +396.2% | 832,964 | +423.6% | 0.03% | +416.7% |
| Q2 2022 | $1,813,000 | -79.1% | 159,078 | -83.3% | 0.01% | -76.9% |
| Q1 2022 | $8,692,000 | +206.9% | 954,164 | +402.7% | 0.03% | +333.3% |
| Q4 2021 | $2,832,000 | +246.2% | 189,791 | +505.2% | 0.01% | +200.0% |
| Q2 2021 | $818,000 | -88.0% | 31,359 | -83.7% | 0.00% | -88.9% |
| Q1 2021 | $6,797,000 | -21.6% | 192,538 | -44.0% | 0.02% | -28.0% |
| Q4 2020 | $8,673,000 | -36.9% | 343,624 | -5.8% | 0.02% | -49.0% |
| Q3 2020 | $13,751,000 | +26.7% | 364,648 | +43.9% | 0.05% | -9.3% |
| Q2 2020 | $10,850,000 | – | 253,393 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |